Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

TNFR2: The new Treg switch?

Cohen JL, Wood KJ.

Oncoimmunology. 2017 Sep 21;7(1):e1373236. doi: 10.1080/2162402X.2017.1373236. eCollection 2017.

2.

Acute Renal Graft-Versus-Host Disease in a Murine Model of Allogeneic Bone Marrow Transplantation.

Schmid PM, Bouazzaoui A, Schmid K, Birner C, Schach C, Maier LS, Holler E, Endemann DH.

Cell Transplant. 2017 Aug;26(8):1428-1440. doi: 10.1177/0963689717720295.

3.

Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding.

Ranganathan P, Ngankeu A, Zitzer NC, Leoncini P, Yu X, Casadei L, Challagundla K, Reichenbach DK, Garman S, Ruppert AS, Volinia S, Hofstetter J, Efebera YA, Devine SM, Blazar BR, Fabbri M, Garzon R.

J Immunol. 2017 Mar 15;198(6):2500-2512. doi: 10.4049/jimmunol.1601778. Epub 2017 Feb 3.

PMID:
28159900
4.

Cyclin-dependent kinase 5 activity is required for allogeneic T-cell responses after hematopoietic cell transplantation in mice.

Askew D, Pareek TK, Eid S, Ganguly S, Tyler M, Huang AY, Letterio JJ, Cooke KR.

Blood. 2017 Jan 12;129(2):246-256. doi: 10.1182/blood-2016-05-702738. Epub 2016 Nov 14.

5.

The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview.

Boieri M, Shah P, Dressel R, Inngjerdingen M.

Front Immunol. 2016 Aug 30;7:333. doi: 10.3389/fimmu.2016.00333. eCollection 2016. Review.

6.

Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?

Zeiser R, Blazar BR.

Blood. 2016 Jun 23;127(25):3117-26. doi: 10.1182/blood-2016-02-699082. Epub 2016 Mar 18.

7.

Differential Effect of MyD88 Signal in Donor T Cells on Graft-versus-Leukemia Effect and Graft-versus-Host Disease after Experimental Allogeneic Stem Cell Transplantation.

Lim JY, Ryu DB, Lee SE, Park G, Choi EY, Min CK.

Mol Cells. 2015 Nov;38(11):966-74. doi: 10.14348/molcells.2015.0158. Epub 2015 Nov 10.

8.

Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies.

Jacoby E, Chen A, Loeb DM, Gamper CJ, Zambidis E, Llosa NJ, Huo J, Cooke KR, Jones R, Fuchs E, Luznik L, Symons HJ.

Biol Blood Marrow Transplant. 2016 Jan;22(1):112-8. doi: 10.1016/j.bbmt.2015.08.034. Epub 2015 Sep 4.

9.

Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantation.

Toubai T, Guoqing H, Rossi C, Mathewson N, Oravecz-Wilson K, Cummings E, Wu J, Sun Y, Choi S, Reddy P.

Oncoimmunology. 2015 Apr 1;4(7):e1016699. eCollection 2015 Jul.

10.

Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation.

Auletta JJ, Eid SK, Wuttisarnwattana P, Silva I, Metheny L, Keller MD, Guardia-Wolff R, Liu C, Wang F, Bowen T, Lee Z, Solchaga LA, Ganguly S, Tyler M, Wilson DL, Cooke KR.

Stem Cells. 2015 Feb;33(2):601-14. doi: 10.1002/stem.1867.

11.

Regulation of acute graft-versus-host disease by microRNA-155.

Ranganathan P, Heaphy CE, Costinean S, Stauffer N, Na C, Hamadani M, Santhanam R, Mao C, Taylor PA, Sandhu S, He G, Shana'ah A, Nuovo GJ, Lagana A, Cascione L, Obad S, Broom O, Kauppinen S, Byrd JC, Caligiuri M, Perrotti D, Hadley GA, Marcucci G, Devine SM, Blazar BR, Croce CM, Garzon R.

Blood. 2012 May 17;119(20):4786-97. doi: 10.1182/blood-2011-10-387522. Epub 2012 Mar 9.

12.

HDAC inhibition and graft versus host disease.

Choi S, Reddy P.

Mol Med. 2011 May-Jun;17(5-6):404-16. doi: 10.2119/molmed.2011.00007. Epub 2011 Jan 8. Review.

13.

Is human cell therapy research caught in a mousetrap?

John Barrett A, Joseph Melenhorst J.

Mol Ther. 2011 Feb;19(2):224-7. doi: 10.1038/mt.2010.304. No abstract available.

14.

The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells.

Takashima S, Kadowaki M, Aoyama K, Koyama M, Oshima T, Tomizuka K, Akashi K, Teshima T.

J Exp Med. 2011 Feb 14;208(2):285-94. doi: 10.1084/jem.20101559. Epub 2011 Jan 31.

15.

Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells.

Meguro A, Ozaki K, Hatanaka K, Oh I, Sudo K, Ohmori T, Matsu H, Tatara R, Sato K, Sakata Y, Nakae S, Leonard WJ, Ozawa K.

Bone Marrow Transplant. 2011 Dec;46(12):1557-65. doi: 10.1038/bmt.2010.342. Epub 2011 Jan 24.

16.

Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation.

Tawara I, Koyama M, Liu C, Toubai T, Thomas D, Evers R, Chockley P, Nieves E, Sun Y, Lowler KP, Malter C, Nishimoto N, Hill GR, Reddy P.

Clin Cancer Res. 2011 Jan 1;17(1):77-88. doi: 10.1158/1078-0432.CCR-10-1198. Epub 2010 Nov 3.

17.

Altered effector CD4+ T cell function in IL-21R-/- CD4+ T cell-mediated graft-versus-host disease.

Oh I, Ozaki K, Meguro A, Hatanaka K, Kadowaki M, Matsu H, Tatara R, Sato K, Iwakura Y, Nakae S, Sudo K, Teshima T, Leonard WJ, Ozawa K.

J Immunol. 2010 Aug 1;185(3):1920-6. doi: 10.4049/jimmunol.0902217. Epub 2010 Jun 23.

18.

Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.

Asakura S, Hashimoto D, Takashima S, Sugiyama H, Maeda Y, Akashi K, Tanimoto M, Teshima T.

J Clin Invest. 2010 Jul;120(7):2370-8. doi: 10.1172/JCI39165. Epub 2010 Jun 7.

19.

Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

Li JM, Giver CR, Lu Y, Hossain MS, Akhtari M, Waller EK.

Immunotherapy. 2009 Jul;1(4):599-621. Review.

20.

Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activation.

Silva IA, Olkiewicz K, Askew D, Fisher JM, Chaudhary MN, Vannella KM, Deurloo DT, Choi SW, Pierce EM, Clouthier SG, Liu C, Cooke KR.

Biol Blood Marrow Transplant. 2010 May;16(5):598-611. doi: 10.1016/j.bbmt.2009.12.007. Epub 2010 Feb 1.

Supplemental Content

Support Center